CoChat

Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years

Nilsson, Sven E., Johansson, Boo, Takkinen, Sanna, Zarit, Steven, McClearn, Gerald, Melander, Arne, Berg, Stig · 2003 · European Journal of Clinical Pharmacology

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.

Abstract

Objective It has been reported that aspirin and other non-steroidal anti-inflammatory drugs (NSAID) may protect against dementia of Alzheimer's type and/or vascular dementia. However, co-morbidity and the dose of aspirin may be critical. A major indication for low-dose aspirin is prophylaxis after stroke and transient ischaemic attacks, conditions that may obscure an anti-dementia effect by the drug. Alternatively, low-dose aspirin may be insufficient if the protective effect is due to an anti-inflammatory mechanism. The aim of this study was to assess whether high-dose or low-dose aspirin may protect against Alzheimer's dementia in subjects aged > or =80 years. For comparison, effects of (other) NSAID, paracetamol and D-propoxyphene were studied.Methods Global, cross-sectional, and longitudinal (1991-2000) epidemiological analyses of clinical, cognitive and drug treatment data on 702 individuals 80 years old or more (351 twin pairs of same sex), all alive at inclusion: mean age 83.9 years (80-99 years). Calculations were made with logistic regression of associations between use of various analgesics and cognitive function, after adjustment for age, gender, and cardiovascular and cerebrovascular diseases.Results Users of high-dose aspirin had significantly lower prevalence of Alzheimer's dementia and better-maintained cognitive function than non-users. There were numerically similar but not significant associations with use of low-dose aspirin and other NSAID. There were no such associations with use of either paracetamol or D-propoxyphene.Conclusion Aspirin might protect against Alzheimer's disease, but controlled trials are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00228-003-0618-y

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 104

Metadata

Authors
Nilsson, S. E., Johansson, B., Takkinen, S., Zarit, S., McClearn, G., Melander, A., & Berg, S.
Affiliations
  • Jönköping University (SE)
  • University of Gothenburg (SE)
  • Pennsylvania State University (US)
  • Lund University (SE)
Corresponding author
Melander, Arne
Venue
European Journal of Clinical Pharmacology
Published
2003-08-01
Volume
59
Issue
4
Pages
313-319
ISSN
  • 0031-6970 (ISSN-L)
  • 1432-1041
OpenAlex
W2064151116
Cited by
104
References
27
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
2.86
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • European Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Pennsylvania State University
  • Karolinska Institutet
  • National Institute on Aging (AG 08861)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
aspirin, Alzheimer's disease, dementia, high-dose aspirin, low-dose aspirin, nonsteroidal anti-inflammatory drugs, paracetamol, analgesic use, cognitive function, oldest old, vascular dementia, anti-inflammatory mechanism
MeSH terms
Acetaminophen, Aged, Aged, 80 and over, Alzheimer Disease, Analgesics, Opioid, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Cognition, Cross-Sectional Studies, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Dextropropoxyphene, Sweden, Twins, Analgesics, Non-Narcotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years. https://app.cochat.ai/papers/10.1007/s00228-003-0618-y
The paper
Nilsson, S. E., Johansson, B., Takkinen, S., Zarit, S., McClearn, G., Melander, A., & Berg, S. (2003). Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-003-0618-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.